Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
2013 · Oncogenesis · 79 citations
https://doi.org/10.1038/oncsis.2013.9
M
María Sánchez‐Aragó
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
2.0K
Citations
22
h-index
26
i10-index
María Sánchez‐Aragó is an academic researcher from GEICAM – Spanish Breast Cancer Group. The author has contributed to research in topics: Mitochondrial Function and Pathology & ATP Synthase and ATPases Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 22, co-authored 31 publications.
Papers by this author
worksAdalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration
2015 · Scientific Reports · 61 citations
https://doi.org/10.1038/srep11764
The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil
2011 · Journal of Translational Medicine · 56 citations
https://doi.org/10.1186/1479-5876-9-19
Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis
2017 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-017-1136-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat